Lista de obras - Tal Burt - Dominio Público Uruguay

A placebo-controlled, randomized withdrawal study of sertraline for major depressive disorder in Japan.

artículo científico publicado en 2006

A randomized, placebo-controlled study of the efficacy and safety of sertraline in the treatment of the behavioral manifestations of Alzheimer's disease in outpatients treated with donepezil.

artículo científico publicado en 2004

Antidepressant Regulatory Warnings, Prescription Patterns, Suicidality and Other Aggressive Behaviors in Major Depressive Disorder and Anxiety Disorders.

artículo científico publicado en 2015

Clinical Research Environment in India: Challenges and Proposed Solutions

artículo científico publicado en 2014

Comparison of duloxetine, escitalopram, and sertraline effects on cytochrome P450 2D6 function in healthy volunteers.

artículo científico publicado en 2007

Does antidepressant therapy improve cognition in elderly depressed patients?

artículo científico publicado en 2003

Donepezil in treatment-resistant bipolar disorder.

artículo científico publicado en 1999

Efficacy, safety, and tolerability of sertraline in patients with late-life depression and comorbid medical illness

artículo científico publicado en 2004

Ethics Standards (HRPP) and Public Partnership (PARTAKE) to Address Clinical Research Concerns in India: Moving Toward Ethical, Responsible, Culturally Sensitive, and Community-Engaging Clinical Research.

artículo científico publicado en 2014

Integrating Pharmacoproteomics into Early-Phase Clinical Development: State-of-the-Art, Challenges, and Recommendations

artículo científico publicado en 2017

Intra-Target Microdosing (ITM): A Novel Drug Development Approach Aimed at Enabling Safer and Earlier Translation of Biological Insights Into Human Testing.

artículo científico publicado en 2017

Intra-Target Microdosing - A Novel Drug Development Approach: Proof of Concept, Safety, and Feasibility Study in Humans.

artículo científico publicado en 2017

Intraarterial Microdosing: A Novel Drug Development Approach, Proof-of-Concept PET Study in Rats

artículo científico publicado en 2015

Knowledge and Perception about Clinical Research Shapes Behavior: Face to Face Survey in Korean General Public.

artículo científico publicado en 2016

Late onset dysthymic disorder and major depression differ from early onset dysthymic disorder and major depression in elderly outpatients

artículo científico publicado en 2004

Microdosing and Other Phase 0 Clinical Trials: Facilitating Translation in Drug Development.

artículo científico publicado en 2016

Microdosing and drug development: past, present and future

artículo científico publicado en 2013

Neuropsychiatric applications of transcranial magnetic stimulation: a meta analysis.

artículo científico publicado en 2002

PARTAKE survey of public knowledge and perceptions of clinical research in India

artículo científico publicado en 2013

Pharmacogenomics in early-phase clinical development

artículo científico publicado en 2013

Pharmacometabolomics in Early-Phase Clinical Development.

artículo científico publicado en 2016

Phase 0, including microdosing approaches: Applying the Three Rs and increasing the efficiency of human drug development

scientific article published on 01 December 2018

Phase 0/microdosing approaches: time for mainstream application in drug development?

artículo científico publicado en 2020

Phase-0/microdosing studies using PET, AMS, and LC-MS/MS: a range of study methodologies and conduct considerations. Accelerating development of novel pharmaceuticals through safe testing in humans - a practical guide.

artículo científico publicado en 2016

Research Question, Study Design and Continuous Research Education and Training Exercises (CREATE) Program

artículo científico publicado en 2012

Sertraline in generalized anxiety disorder: efficacy in treating the psychic and somatic anxiety factors.

artículo científico publicado en 2005

Strategic, feasibility, economic, and cultural aspects of phase 0 approaches

artículo científico publicado en 2022

The Burden of the "False-Negatives" in Clinical Development: Analyses of Current and Alternative Scenarios and Corrective Measures.

artículo científico publicado en 2017

Thyroid Autoimmune Antibodies and Major Depressive Disorder in Women

artículo científico publicado en 2015

Vagus nerve stimulation: a new tool for brain research and therapy.

artículo científico publicado en 2000

Lista de obras de Tal Burt

A placebo-controlled, randomized withdrawal study of sertraline for major depressive disorder in Japan.

A randomized, placebo-controlled study of the efficacy and safety of sertraline in the treatment of the behavioral manifestations of Alzheimer's disease in outpatients treated with donepezil.

Antidepressant Regulatory Warnings, Prescription Patterns, Suicidality and Other Aggressive Behaviors in Major Depressive Disorder and Anxiety Disorders.

Clinical Research Environment in India: Challenges and Proposed Solutions

Comparison of duloxetine, escitalopram, and sertraline effects on cytochrome P450 2D6 function in healthy volunteers.

Does antidepressant therapy improve cognition in elderly depressed patients?

Donepezil in treatment-resistant bipolar disorder.

Efficacy, safety, and tolerability of sertraline in patients with late-life depression and comorbid medical illness

Ethics Standards (HRPP) and Public Partnership (PARTAKE) to Address Clinical Research Concerns in India: Moving Toward Ethical, Responsible, Culturally Sensitive, and Community-Engaging Clinical Research.

Integrating Pharmacoproteomics into Early-Phase Clinical Development: State-of-the-Art, Challenges, and Recommendations

Intra-Target Microdosing (ITM): A Novel Drug Development Approach Aimed at Enabling Safer and Earlier Translation of Biological Insights Into Human Testing.

Intra-Target Microdosing - A Novel Drug Development Approach: Proof of Concept, Safety, and Feasibility Study in Humans.

Intraarterial Microdosing: A Novel Drug Development Approach, Proof-of-Concept PET Study in Rats

Knowledge and Perception about Clinical Research Shapes Behavior: Face to Face Survey in Korean General Public.

Late onset dysthymic disorder and major depression differ from early onset dysthymic disorder and major depression in elderly outpatients

Microdosing and Other Phase 0 Clinical Trials: Facilitating Translation in Drug Development.

Microdosing and drug development: past, present and future

Neuropsychiatric applications of transcranial magnetic stimulation: a meta analysis.

PARTAKE survey of public knowledge and perceptions of clinical research in India

Pharmacogenomics in early-phase clinical development

Pharmacometabolomics in Early-Phase Clinical Development.

Phase 0, including microdosing approaches: Applying the Three Rs and increasing the efficiency of human drug development

Phase 0/microdosing approaches: time for mainstream application in drug development?

Phase-0/microdosing studies using PET, AMS, and LC-MS/MS: a range of study methodologies and conduct considerations. Accelerating development of novel pharmaceuticals through safe testing in humans - a practical guide.

Research Question, Study Design and Continuous Research Education and Training Exercises (CREATE) Program

Sertraline in generalized anxiety disorder: efficacy in treating the psychic and somatic anxiety factors.

Strategic, feasibility, economic, and cultural aspects of phase 0 approaches

The Burden of the "False-Negatives" in Clinical Development: Analyses of Current and Alternative Scenarios and Corrective Measures.

Thyroid Autoimmune Antibodies and Major Depressive Disorder in Women

Vagus nerve stimulation: a new tool for brain research and therapy.